SCHEMBL196782

SCHEMBL196782

O=C(O)[C@H](O)c1ccccc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
MAPK1 P28482 1/20 0.52
GLS O94925 1/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN7 P35236 1/20 0.41
BLM P54132 1/20 0.41
ESR2 Q92731 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
SRC P12931 2/20 0.38
CYP2D6 P10635 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38
CES2 O00748 2/20 0.38
CES1 P23141 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30670484 1.00 LMNA (0.52) LMNAMAPK1GLSHTTKMT2A
SCHEMBL196781 1.00 LMNA (0.52) LMNAMAPK1GLSHTTKMT2A
SCHEMBL8127769 1.00 LMNA (0.52) LMNAMAPK1GLSHTTKMT2A
SCHEMBL275598 0.84 LMNA (0.64) LMNAMAPK1KMT2APOLBPKM
SCHEMBL9744991 0.82 CES2 (0.57) LMNAMAPK1GLSHTTKMT2A
SCHEMBL29172241 0.81 HTT (0.45) LMNAMAPK1GLSHTTIDO1
SCHEMBL18512243 0.80 CES2 (0.45) LMNAMAPK1GLSHTTKMT2A
SCHEMBL26669676 0.80 CES2 (0.45) LMNAMAPK1GLSHTTKMT2A
SCHEMBL28553187 0.80 HPGD (0.42) LMNAMAPK1GLSHTTKMT2A
SCHEMBL20930584 0.80 CYP2D6 (0.50) LMNAMAPK1HTTKMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113355367-B Application of ketoacid reductase in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2024-03-26 CN claimed
US-20220325035-A1 POLYESTER, POLYESTERAMIDE, AND POLYAMIDE COMPOSITIONS IYER ANANTH V (US) 2022-10-13 US claimed
CN-113355299-B Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2022-05-24 CN claimed
CN-113355367-A Application of ketoacid reductase in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-09-07 CN claimed
CN-113355299-A Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-09-07 CN claimed
CN-108410831-B Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-07-27 CN claimed
CN-113355367-B Application of ketoacid reductase in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2024-03-26 CN disclosed
US-20220325035-A1 POLYESTER, POLYESTERAMIDE, AND POLYAMIDE COMPOSITIONS IYER ANANTH V (US) 2022-10-13 US disclosed
CN-109689667-B Porous chiral material and use thereof 南开大学 2022-07-12 CN disclosed
CN-113355299-B Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2022-05-24 CN disclosed
CN-113355367-A Application of ketoacid reductase in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-09-07 CN disclosed
CN-113355299-A Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-09-07 CN disclosed
CN-108410831-B Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid 浙江工业大学 2021-07-27 CN disclosed
WO-2003097810-A2 NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM DIVERSA CORPORATION (US) 2003-11-27 WO disclosed
US-6653498-B2 Reacting an aldehyde with hydrogen cyanide in a water immiscible organic solvent and water, using the enzyme (R)-hydroxynitrile lyase CLARIANT GMBH (DE) 2003-11-25 US disclosed
US-20030124698-A1 Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia DIVERSA CORPORATION 2003-07-03 US disclosed
EP-1302458-A1 ESTER DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-04-16 EP disclosed
WO-2003000840-A2 NITRILASES DIVERSA CORPORATION (US) 2003-01-03 WO disclosed
EP-1219593-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINOALCOHOL Mitsubishi Rayon Co., Ltd. (JP) 2002-07-03 EP disclosed
US-20020052523-A1 Process for preparing optically active cyanohydrins and secondary products CLARIANT GMBH 2002-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052523-A1 Process for preparing optically active cyanohydrins and secondary products DOHH, OGDH, AOX1 LMNA 542/4885MAPK1 2827/4885GLS 894/4885
US-20030124698-A1 Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia NIT2, DNPH1, ASNS LMNA 1094/4885MAPK1 4224/4885GLS 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.